Asthma
Not recruitingStudy on GSK5784283 for Adults Aged 18-75 with Uncontrolled Asthma
- Disease:Asthma
- Substances:GSK5784283
Bulgaria- Participants:18–64 years · 65+ years
- Substances:GSK5784283
- Sponsor:Glaxosmithkline Research & Development Limited
Rare diseases
Investigational molecules
Locations
Back to Bulgaria54 clinical trials in Vratsa, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on asthma and COPD treatments, evaluating novel therapies and combinations to improve lung function and reduce exacerbations.
Multiple trials testing innovative inhaler formulations and biological treatments for better disease control.
Groundbreaking studies in breast cancer and leukemia, with particular focus on targeted therapies and combination treatments.
Innovative approaches combining established treatments with novel therapeutic agents.
Comprehensive research in psychiatric disorders, including trials for schizophrenia, anxiety, and depression treatments.
Focus on developing effective adjunctive therapies and new treatment options for resistant cases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.